Qiagen NV (QGEN)

Sep 26, 2026

Qiagen N.V. (NYSE:QGEN) has received an average "Hold" rating from 14 brokerages, with a consensus 12-month price target of $43.51, slightly below its current trading price of $44.15. The company recently exceeded quarterly earnings and revenue expectations, reporting $0.62 per share on $535.04 million in revenue. Institutional investors hold approximately 70% of Qiagen's stock.

Sep 25, 2026

State Street Corp increased its holdings in Qiagen N.V. (NYSE:QGEN) by 4.5% during the second quarter, bringing its total stake to 2.18 million shares valued at approximately $85.4 million. Qiagen exceeded analyst expectations for its recent quarterly earnings, reporting adjusted EPS of $0.62 against a $0.60 consensus and revenue of $535.0 million against estimates of $527.5 million, while maintaining its fiscal 2026 EPS guidance. Despite shares opening higher, analysts currently maintain an average "Hold" rating with a consensus price target slightly below the current share price.

Sep 22, 2026

Qiagen NV (QGEN) shares recently rose 3.4% to $44.78 and are considered "Modestly Undervalued" according to GuruFocus' GF Value estimate of $49.88, offering a 10.2% margin of safety. The company boasts a strong GF Score™ of 75/100, particularly in valuation (10/10), although growth (4/10) is an area for investor consideration. While gurus show mixed sentiment, the absence of insider transactions over the past year suggests stable insider confidence in the company's prospects.

Sep 18, 2026

Qiagen NV (QGEN) shares surged 3.5% to $44.38, and the stock is currently assessed as modestly undervalued by GuruFocus's GF Value™ with a fair value of $49.41. The company holds a GF Score™ of 75/100, indicating above-average performance, particularly strong in valuation (10/10) and profitability (7/10), despite lower growth potential. While gurus are active, adding and trimming positions, there have been no insider transactions in the past year.

Sep 14, 2026

Engineers Gate Manager LP significantly increased its stake in Qiagen (NYSE:QGEN) by 107.7% in the second quarter, bringing its holdings to 74,567 shares valued at $2.9 million. This increase follows Qiagen's strong quarterly performance, where it exceeded analyst expectations for earnings and revenue, reporting $0.62 EPS and $535.04 million in revenue. Despite a consensus "Hold" rating from analysts with an average price target of $43.51, institutional investors collectively own 70% of the company's stock, reflecting continued interest.

Sep 13, 2026

WINTON GROUP Ltd recently acquired 36,400 shares of Qiagen N.V. (NYSE:QGEN) for approximately $1.42 million during the second quarter. This purchase contributes to the roughly 70% institutional ownership of Qiagen's stock. The company exceeded its quarterly earnings expectations with an EPS of $0.62 and revenue of $535.04 million, while analysts currently maintain a consensus "Hold" rating with an average price target of $43.51.